Table III.
Outcome summary for all surgical treatments.
| Study | Mean follow-up, mths (range) |
Primary treatment | Cysts | Failure (%) |
Recurrence (%) |
|---|---|---|---|---|---|
| Aiba 2018 |
55 (16 to 149) | Endoscopic curettage | 30 | 9 (30) | 3 (10) |
| Rahman 2018 |
51 (24 to 78) | Curettage + burr + cryosurgery + bone graft | 16 | 1 (6) | |
| Mostafa 2017 |
45 (24 to 68) | Curettage + argon beam coagulation + bone graft | 15 | 1 (7) | |
| Crowe 2015 |
29 (13 to 56) | Curettage ± burr ± phenol ± argon beam ± H2O2 + bone graft | 10 | 1 (10) | |
| En bloc resection + bone graft + internal fixation | 1 | 0 (0) | |||
| Erol 2015 |
66 (28 to 130)* | Curettage + burr ± bone graft ± PMMA ± internal fixation ± preoperative embolization | 59 | 2 (3) | 2 (3) |
| En bloc resection ± bone graft ± endoprosthetic reconstruction ± internal fixation | 5 | 0 (0) | 0 (0) | ||
| Kececi 2014 |
108 (48 to 300) | Curettage ± bone graft ± PMMA | 14 | 1 (7) | |
| Curettage + burr ± bone graft ± PMMA | 19 | 3 (16) | |||
| Curettage + burr + alcohol + phenol ± bone graft ± PMMA | 43 | 6 (14) | |||
| En bloc resection | 9 | 0 (0) | |||
| Wang 2014 |
84 (24 to 216) | Curettage + burr ± internal fixation | 31 | 1 (3) | |
| Flont 2013 |
110 (36 to 228) | Curettage + burr ± bone graft | 16 | 2 (13) | |
| En bloc resection ± bone graft | 10 | 0 (0) | |||
| Ibrahim 2012 |
40 (24 to 70) | Percutaneous curettage and suction | 9 | 1 (11) | 1 (11) |
| Curettage + burr ± bone graft ± internal fixation | 8 | 1 (13) | 0 (0) | ||
| Cummings 2010 |
39 (19 to 88) | Curettage + burr + argon beam ± bone graft | 17 | 0 (0) | |
| Curettage + burr ± phenol ± bone graft | 12 | 4 (33) | |||
| Docquier 2010 |
53 (24 to 106) | Open biopsy + DBP ± BM ± TPC | 21 | 5 (24) | |
| Peeters 2009 |
55 (24 to 122) | Curettage + burr + cryosurgery ± bone grafting ± internal fixation | 80 | 4 (5) | |
| Lin 2008 |
35 (24 to 112) | Curettage ± burr + bone graft | 53 | 10 (19) | |
| Basarir 2007 |
48 (24 to 194) | Curettage + bone graft | 23 | 6 (26) | |
| En bloc resection | 19 | 0 (0) | |||
| Radiation therapy | 2 | 1 (50) | |||
| Curettage ± cauterization ± PMMA + bone graft | 12 | 2 (17) | |||
| Dormans 2004 |
46 (24 to 99) | Curettage ± burr ± caterization ± phenol ± H2O2 ± preoperative embolization±bone graft | 44 | 8 (18) | |
| En bloc resection | 1 | 0 (0) | |||
| Ramirez 2002 |
62 (26 to 117) | Curettage + bone graft | 23 | 8 (35) | |
| En bloc resection ± bone graft ± spinal fusion | 6 | 0 (0) |
“±” here designates “with or without”.
*
Median follow-up (interquartile range).
BM, bone marrow; DBP, demineralized bone powder; PMMA, polymethyl methacrylate; TPC, tricalcium phosphate cylinder.